14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoic acid

Term ID

CHEBI:140258

Synonyms

(7Z,10Z,12E,14S,16Z,19Z)-14,21-dihydroxydocosa-7,10,12,16,19-pentaenoic acid
(7Z,10Z,12E,14S,16Z,19Z)-14,21-dihydroxydocosapentaenoic acid
14(S),21-dihydroxy-omega3-docosapentaenoic acid
MaR3n-3 DPA

Definition

A docosanoid that is (7Z,10Z,12E,16Z,19Z)-docosapentaenoic acid carrying two hydroxy substituents at positions 14S and 21. An intermediate of specialised proresolving mediators.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: docosanoid hydroxy polyunsaturated fatty acid long-chain fatty acid secondary allylic alcohol

docosanoid hydroxy polyunsaturated fatty acid long-chain fatty acid secondary allylic alcohol Show first 5 Terms
has_role: anti-inflammatory agent human xenobiotic metabolite

anti-inflammatory agent human xenobiotic metabolite Show first 5 Terms
inverse is_conjugate_base_of: 14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoate

14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoate Show first 5 Terms
is_conjugate_acid_of: 14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoate

14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoate Show first 5 Terms

Phenotype

Phenotype resulting from 14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoic acid

Phenotype where environments contain 14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoic acid

Phenotype modified by environments containing 14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoic acid

Human Disease Model